FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2621964837> ?p ?o ?g. }

• W2621964837 endingPage "194" @default.
• W2621964837 startingPage "185" @default.
• W2621964837 abstract "Background: The purpose of this study was to examine the anti-atherogenic and anti-inflammatory effect of supplemental taurine prior to and following incremental exercise in patients with heart failure (HF). Methods: Patients with HF and left ventricle ejection fraction less than 50%, and placed in functional class II or III according to the New York Heart Association classification, were randomly assigned to two groups: (1) taurine supplementation; or (2) placebo. The taurine group received oral taurine (500 mg) 3 times a day for 2 weeks, and performed exercise before and after the supplementation period. The placebo group followed the same protocol, but with a starch supplement (500 mg) rather than taurine. The incremental multilevel treadmill test was done using a modified Bruce protocol. Results: Our results indicate that inflammatory indices [C-reactive protein (CRP), platelets] decreased in the taurine group in pre-exercise, post-supplementation and post-exercise, post-supplementation as compared with pre-exercise, pre-supplementation ( p < 0.05) whereas these indices increased in pre-exercise, post-supplementation and post-exercise, post-supplementation as compared with pre-exercise, pre-supplementation in the placebo group ( p < 0.05). Our results also show that atherogenic indices [Castelli’s Risk Index-I (CRI-I), Castelli’s Risk Index-II (CRI-II) and Atherogenic Coefficient (AC)] decreased in the taurine group in pre-exercise, post-supplementation and post-exercise, post-supplementation as compared with pre-exercise, pre-supplementation ( p < 0.05). No such changes were noted in the placebo group ( p > 0.05). Conclusions: our results suggest that 2 weeks of oral taurine supplementation increases the taurine levels and has anti-atherogenic and anti-inflammatory effects prior to and following incremental exercise in HF patients." @default.
• W2621964837 created "2017-06-15" @default.
• W2621964837 creator A5003740311 @default.
• W2621964837 creator A5036594393 @default.
• W2621964837 creator A5048892177 @default.
• W2621964837 creator A5066296876 @default.
• W2621964837 date "2017-06-05" @default.
• W2621964837 modified "2023-10-12" @default.
• W2621964837 title "Taurine supplementation has anti-atherogenic and anti-inflammatory effects before and after incremental exercise in heart failure" @default.
• W2621964837 cites W113644040 @default.
• W2621964837 cites W1591662454 @default.
• W2621964837 cites W1863056285 @default.
• W2621964837 cites W1963778567 @default.
• W2621964837 cites W1968690534 @default.
• W2621964837 cites W2017602185 @default.
• W2621964837 cites W2020647661 @default.
• W2621964837 cites W2028815510 @default.
• W2621964837 cites W2030420586 @default.
• W2621964837 cites W2031162377 @default.
• W2621964837 cites W2034549365 @default.
• W2621964837 cites W2062128240 @default.
• W2621964837 cites W2074926882 @default.
• W2621964837 cites W2080101589 @default.
• W2621964837 cites W2080231335 @default.
• W2621964837 cites W2082795572 @default.
• W2621964837 cites W2090188376 @default.
• W2621964837 cites W2100747157 @default.
• W2621964837 cites W2105951351 @default.
• W2621964837 cites W2111792632 @default.
• W2621964837 cites W2112259565 @default.
• W2621964837 cites W2116404316 @default.
• W2621964837 cites W2121504925 @default.
• W2621964837 cites W2138553207 @default.
• W2621964837 cites W2142194547 @default.
• W2621964837 cites W2142525108 @default.
• W2621964837 cites W2143676228 @default.
• W2621964837 cites W2166504467 @default.
• W2621964837 cites W2171294792 @default.
• W2621964837 cites W2203423340 @default.
• W2621964837 cites W99788924 @default.
• W2621964837 doi "https://doi.org/10.1177/1753944717711138" @default.
• W2621964837 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5933646" @default.
• W2621964837 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28580833" @default.
• W2621964837 hasPublicationYear "2017" @default.
• W2621964837 type Work @default.
• W2621964837 sameAs 2621964837 @default.
• W2621964837 citedByCount "32" @default.
• W2621964837 countsByYear W26219648372018 @default.
• W2621964837 countsByYear W26219648372019 @default.
• W2621964837 countsByYear W26219648372020 @default.
• W2621964837 countsByYear W26219648372021 @default.
• W2621964837 countsByYear W26219648372022 @default.
• W2621964837 countsByYear W26219648372023 @default.
• W2621964837 crossrefType "journal-article" @default.
• W2621964837 hasAuthorship W2621964837A5003740311 @default.
• W2621964837 hasAuthorship W2621964837A5036594393 @default.
• W2621964837 hasAuthorship W2621964837A5048892177 @default.
• W2621964837 hasAuthorship W2621964837A5066296876 @default.
• W2621964837 hasBestOaLocation W26219648371 @default.
• W2621964837 hasConcept C126322002 @default.
• W2621964837 hasConcept C130049864 @default.
• W2621964837 hasConcept C134018914 @default.
• W2621964837 hasConcept C142724271 @default.
• W2621964837 hasConcept C185592680 @default.
• W2621964837 hasConcept C204787440 @default.
• W2621964837 hasConcept C27081682 @default.
• W2621964837 hasConcept C2777953023 @default.
• W2621964837 hasConcept C2778198053 @default.
• W2621964837 hasConcept C2778856057 @default.
• W2621964837 hasConcept C2778921608 @default.
• W2621964837 hasConcept C2779701627 @default.
• W2621964837 hasConcept C2781464450 @default.
• W2621964837 hasConcept C515207424 @default.
• W2621964837 hasConcept C55493867 @default.
• W2621964837 hasConcept C71924100 @default.
• W2621964837 hasConcept C78085059 @default.
• W2621964837 hasConcept C84393581 @default.
• W2621964837 hasConceptScore W2621964837C126322002 @default.
• W2621964837 hasConceptScore W2621964837C130049864 @default.
• W2621964837 hasConceptScore W2621964837C134018914 @default.
• W2621964837 hasConceptScore W2621964837C142724271 @default.
• W2621964837 hasConceptScore W2621964837C185592680 @default.
• W2621964837 hasConceptScore W2621964837C204787440 @default.
• W2621964837 hasConceptScore W2621964837C27081682 @default.
• W2621964837 hasConceptScore W2621964837C2777953023 @default.
• W2621964837 hasConceptScore W2621964837C2778198053 @default.
• W2621964837 hasConceptScore W2621964837C2778856057 @default.
• W2621964837 hasConceptScore W2621964837C2778921608 @default.
• W2621964837 hasConceptScore W2621964837C2779701627 @default.
• W2621964837 hasConceptScore W2621964837C2781464450 @default.
• W2621964837 hasConceptScore W2621964837C515207424 @default.
• W2621964837 hasConceptScore W2621964837C55493867 @default.
• W2621964837 hasConceptScore W2621964837C71924100 @default.
• W2621964837 hasConceptScore W2621964837C78085059 @default.
• W2621964837 hasConceptScore W2621964837C84393581 @default.
• W2621964837 hasIssue "7" @default.
• W2621964837 hasLocation W26219648371 @default.
• W2621964837 hasLocation W26219648372 @default.

• next